1.42
price down icon6.58%   -0.10
after-market After Hours: 1.43 0.01 +0.70%
loading

Lava Therapeutics Nv Stock (LVTX) Forecast

The Lava Therapeutics Nv (LVTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.4521, representing a +283.95% increase from the current price of $1.42. The highest analyst price target is $5.404, and the lowest is $5.5003.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LVTX Price Target
Average 3.2785 (+130.88% Upside)
loading

Is Lava Therapeutics Nv (LVTX) A Buy Now?

Oscillators
Name Value Action
RSI(14) 51.09 Neutral
STOCH(9,6) 38.21 Neutral
STOCHRSI(14) 42.35 Neutral
MACD(12,26) 0.0345 Sell
ADX(14) 58.35 Buy
William %R -75.00 Neutral
CCI(14) -19.76 Neutral
Buy: 1 Sell: 1 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
1.459
Sell
1.4502
Sell
MA20
1.4223
Sell
1.4247
Sell
MA50
1.3572
Buy
1.3698
Buy
MA100
1.3092
Buy
1.3385
Buy
MA200
1.3182
Buy
1.4661
Sell
Buy: 5 Sell: 5 Neutral: 0
Summary: Neutral
According to our latest analysis, LVTX could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on LVTX, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 51.09 indicates that LVTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 38.21 indicates that LVTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 42.35 indicates that LVTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 58.35 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -19.76 indicates that LVTX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term LVTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Lava Therapeutics Nv financial reports and earnings history, Lava Therapeutics Nv (LVTX) stock could reach $10.06 by 2030, $37.72 by 2040 and $73.15 by 2050. See the projected annual prices until 2050 of the Lava Therapeutics Nv stock below:

  • Lava Therapeutics Nv (LVTX) is expected to reach an average price of $35.92 in 2035, with a high prediction of $35.32 and a low estimate of $33.67. This indicates an $2,429% rise from the last recorded price of $1.42.
  • Lava Therapeutics Nv (LVTX) stock is projected to chart a bullish course in 2040, with an average price target of $37.32, representing an $2,528% surge from its current level. The forecast ranges from a conservative $37.42 to a sky-high $37.72.
  • Our analysts predict Lava Therapeutics Nv (LVTX) to jump 1,455% by 2045, soaring from $22.22 to an average price of $22.08, potentially reaching $23.23. While $22.22 is the low estimate, the potential upside is significant.
  • Lava Therapeutics Nv (LVTX) stock is expected to climb by 2050, reaching an average of $72.81, a $5,027% jump from its current level. However, a wide range of estimates exists, with high and low targets of $73.15 and $72.92, respectively, highlighting the market's uncertainty.

Lava Therapeutics Nv Stock (LVTX) Year by Year Forecast

Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2025

Lava Therapeutics Nv Stock (LVTX) is expected to reach an average price of $4.2271 in 2025, with a high prediction of $5.404 and a low estimate of $3.0501. This indicates an +197.68% rise from the last recorded price of $1.42.
Month Average Low High Change from today's price
September, 2025 $6.114 $5.5003 $5.404 +330.56%
October, 2025 $5.4683 $5.0796 $5.2083 +285.09%
November, 2025 $5.2957 $5.4057 $5.2189 +272.94%
December, 2025 $5.1501 $5.3101 $5.2107 +262.68%

Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2026

The predicted value for Lava Therapeutics Nv (LVTX) in 2026 is set at an average of $3.1184. Estimates vary from a peak of $5.0838 to a trough of $1.153, indicating an +119.60% surge from the present price of $1.42.
Month Average Low High Change from today's price
January, 2026 $3.8475 $3.1206 $5.0838 +170.95%
February, 2026 $2.8949 $2.9949 $3.4044 +103.87%
March, 2026 $1.2624 $1.8524 $2.1187 -11.10%
April, 2026 $3.3467 $1.153 $2.7468 +135.68%
May, 2026 $3.0741 $3.0173 $2.7704 +116.49%
June, 2026 $2.8116 $2.8116 $2.871 +98.00%
July, 2026 $4.0659 $3.929 $3.9022 +186.33%
August, 2026 $4.4133 $4.3365 $4.2296 +210.80%
September, 2026 $3.7576 $3.9676 $4.0208 +164.62%
October, 2026 $2.7651 $3.535 $3.5945 +94.72%
November, 2026 $3.1225 $3.1625 $3.0157 +119.90%
December, 2026 $3.0068 $3.0767 $3.0494 +111.75%

Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Lava Therapeutics Nv (LVTX) is $5.7187, with a high forecast of $11.41 and a low forecast of $0.0287. This indicates an +302.72% increase from the last price of $1.42.
Month Average Low High Change from today's price
January, 2027 $3.0243 $3.0137 $2.9305 +112.98%
February, 2027 $2.753 $2.8117 $2.738 +93.87%
March, 2027 $2.846 $2.856 $2.8054 +100.42%
April, 2027 $2.5835 $2.8235 $2.7847 +81.93%
May, 2027 $2.2709 $2.2909 $2.3803 +59.92%
June, 2027 $1.7052 $1.9352 $2.1473 +20.09%
July, 2027 $1.6227 $1.7127 $1.7389 +14.27%
August, 2027 $1.0101 $1.1951 $1.4895 -28.87%
September, 2027 $0.8356 $0.0344 $3.443 -41.16%
October, 2027 $0.1081 $0.0372 $1.4487 -92.38%
November, 2027 $9.25 $0.0287 $7.24 +551.41%
December, 2027 $12.01 $9.5512 $11.41 +745.68%

Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2028

In 2028, Lava Therapeutics Nv (LVTX) is projected to reach an average price of $14.10, with a high projection of $16.38 and a low estimate of $11.83. This indicates an +893.11% rise from the last price of $1.42.
Month Average Low High Change from today's price
January, 2028 $12.13 $11.83 $11.40 +754.47%
February, 2028 $11.99 $12.06 $12.03 +744.25%
March, 2028 $14.63 $12.00 $12.45 +930.07%
April, 2028 $16.20 $16.57 $16.38 +1,041%
May, 2028 $15.46 $15.38 $15.15 +988.77%
June, 2028 $13.85 $15.21 $15.15 +875.03%
July, 2028 $13.36 $13.41 $13.56 +840.86%
August, 2028 $13.25 $13.46 $13.18 +833.02%
September, 2028 $14.26 $14.08 $14.41 +904.49%
October, 2028 $13.68 $14.35 $14.07 +863.29%
November, 2028 $14.25 $13.43 $13.94 +903.33%
December, 2028 $13.48 $14.12 $13.80 +849.45%

Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2029

The 2029 price forecast for Lava Therapeutics Nv Stock (LVTX) is $10.98 on average, with a high prediction of $13.95 and a low estimate of $8.0059. This represents an +672.98% increase from the previous price of $1.42.
Month Average Low High Change from today's price
January, 2029 $13.62 $13.66 $13.61 +859.21%
February, 2029 $13.46 $13.75 $13.40 +847.93%
March, 2029 $13.91 $13.96 $13.95 +879.62%
April, 2029 $13.63 $13.88 $13.80 +859.54%
May, 2029 $13.44 $13.31 $13.34 +846.76%
June, 2029 $13.11 $13.16 $13.19 +823.16%
July, 2029 $12.77 $12.87 $12.92 +799.57%
August, 2029 $10.72 $10.61 $12.63 +655.10%
September, 2029 $9.2873 $9.6672 $9.9999 +554.04%
October, 2029 $7.0759 $8.0059 $8.581 +398.31%
November, 2029 $9.5208 $9.7808 $9.4935 +570.48%
December, 2029 $9.2157 $9.4357 $9.352 +548.99%

Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2030

Lava Therapeutics Nv Stock (LVTX) is expected to reach an average price of $8.0265 in 2030, with a high forecast of $10.18 and a low forecast of $5.8739. This signifies an +465.25% surge from the last price of $1.42.
Month Average Low High Change from today's price
January, 2030 $10.08 $9.1332 $10.06 +610.16%
February, 2030 $10.31 $10.04 $10.18 +626.00%
March, 2030 $9.8441 $9.8741 $10.07 +593.25%
April, 2030 $9.269 $9.299 $9.6878 +552.75%
May, 2030 $8.4576 $8.6076 $9.0127 +495.61%
June, 2030 $8.1125 $8.2425 $8.2213 +471.30%
July, 2030 $7.9211 $7.8474 $7.9199 +457.82%
August, 2030 $7.356 $7.406 $7.6248 +418.03%
September, 2030 $7.2409 $7.2409 $7.2297 +409.92%
October, 2030 $6.9895 $7.0485 $7.0946 +392.22%
November, 2030 $6.2244 $6.3744 $6.7882 +338.34%
December, 2030 $5.7793 $5.8739 $6.0981 +306.99%
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):